PRP (platelet-rich plasma) and PRF (platelet-rich fibrin) are both autologous blood concentrates, but published clinical research does not prove that one is better than the other for patients. The comparative evidence documented in medical literature is restricted to laboratory bench testing rather than clinical patient outcomes.
Choosing between prp vs prf requires looking past marketing claims. Patients should understand how blood processing alters the final substance, what test-tube studies actually measured, and why device clearance differs from clinical approval.
PRP and PRF at a Glance
Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) are both autologous blood preparations, but they differ in blood processing, physical consistency, and the presence of anticoagulants. Medical Frontier found no completed head-to-head randomized clinical trials demonstrating that one option provides superior symptom relief or clinical recovery over the other. The table below summarizes how these two autologous concentrates compare based on documented laboratory and regulatory data.
| Comparison Factor | PRP (Platelet-Rich Plasma) | PRF (Platelet-Rich Fibrin) |
|---|---|---|
| Source material | Patient’s own drawn blood | Patient’s own drawn blood |
| Anticoagulant additive | Yes (blood is mixed with an anticoagulant) | No (blood is prepared without an anticoagulant) |
| Centrifuge spin approach | Commonly described as a faster spin | Commonly described as a slower spin |
| Resulting physical state | Liquid plasma | Fibrin clot, gel, or lower-spin liquid |
| Lab growth-factor pattern | Higher initial release in test tubes | Slower, sustained release past day 10 in vitro |
| FDA regulatory status | Preparation kits cleared as devices; use is off-label | No FDA-approved PRF treatment found; verify the clinic’s device clearance |
| Typical US cost | $400 to $2,000 per session (Medical Frontier estimate) | Unpublished nationally; clinics price individually |
| Clinical comparison evidence | No clinical superiority shown in patient trials | No clinical superiority shown in patient trials |
How Each Blood Product Is Prepared
The distinction between PRP and PRF begins at the blood draw and depends on the processing protocol.
Platelet-rich plasma preparation involves taking blood drawn from a patient and mixing it with an anticoagulant. The anticoagulant prevents the blood from clotting inside the collection tube. A clinical provider places this vial into a centrifuge machine that spins the blood at a higher speed. This spin separates the cellular components into distinct layers. The provider draws off the concentrated liquid platelet layer, which remains fluid because of the anticoagulant additive. Clinicians can then use this concentrated platelet fluid for injection.
Platelet-rich fibrin preparation omits chemical anticoagulants. A provider draws the patient’s blood and spins it at a lower speed. Because no anticoagulant is present, the blood clots during or after the spin. The platelets sit inside a fibrin clot or gel rather than a liquid.
Clinics and academic literature refer to several distinct PRF preparations, though clinics often use these labels inconsistently:
- Leukocyte- and platelet-rich fibrin (L-PRF).
- Advanced platelet-rich fibrin (A-PRF).
- Injectable platelet-rich fibrin (i-PRF), a liquid form made with an even lower spin.
Because preparation protocols, centrifuge speeds, and spin durations vary across equipment manufacturers, the exact composition of both PRP and PRF differs from clinic to clinic.
What Laboratory Studies Reveal
The comparative evidence we found comes from in vitro laboratory experiments.
A systematic review and meta-analysis published by Pereira and colleagues in the International Journal of Molecular Sciences in 2023 evaluated advanced platelet-rich fibrin against other platelet concentrates. That review identified seven laboratory studies for its qualitative synthesis and included four in its quantitative meta-analysis.
The review reported distinct release kinetics between the preparations:
- PRP demonstrated higher initial growth-factor concentrations immediately following preparation.
- A-PRF demonstrated higher sustained growth-factor concentrations after the tenth day of incubation in laboratory dishes.
These findings come from laboratory measurements. All included studies were laboratory studies and assessed no clinical outcomes. The authors of the 2023 review emphasized that the meta-analysis pooled “other platelet concentrates” together as a comparison control group, meaning the data did not isolate PRP alone against PRF.
Furthermore, the certainty of evidence across the included laboratory studies ranged from very low to moderate under the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Every study reviewed carried a moderate risk of bias, driven primarily by a lack of blinding and absent randomization. The review authors explicitly warned readers against extrapolating these cell-culture observations to human patient care and stated that randomized clinical trials are needed.
PRP vs PRF: What Clinical Evidence Shows
While laboratory data shows differences in growth-factor timing, clinical trial evidence evaluating patient outcomes remains sparse.
Medical Frontier reviewed published medical literature and found zero completed, randomized head-to-head clinical trials comparing PRF with PRP for knee osteoarthritis, hair loss, or skin aesthetics. This finding reflects our search of the sources reviewed for this page, rather than proof none exists. Claims that PRF yields superior outcomes for knee osteoarthritis, hair loss, or skin over PRP lack support from published randomized human trials.
In dental surgery, comparative human data exists but does not demonstrate clear superiority. A 2022 systematic review published in the Journal of Indian Society of Periodontology evaluated different autologous platelet concentrates used in treating periodontal intrabony gum and bone defects. The review found no significant differences in outcome between different platelet concentrates. These findings are specific to dental gum pockets and cannot be generalized to orthopedic joints or cosmetic procedures.
Without head-to-head randomized trials measuring clinical endpoints such as pain, function, or healing, assertions that PRF works better than PRP remain unproven.
FDA Regulatory Status and Safety Profiles
PRP is not approved by the Food and Drug Administration (FDA) as a treatment for joints, hair, or skin, and Medical Frontier did not find an FDA-approved PRF treatment.
Preparation kits for PRP are cleared as medical devices, while PRF is likewise prepared and used under the practice of medicine. A device clearance covers the equipment, not the use. It does not evaluate whether the injection has any clinical effect. Clinics use PRP off-label, and PRF is likewise used under the practice of medicine.
Patients evaluating regenerative therapies should review the FDA consumer alert on regenerative medicine, which warns against unapproved regenerative medicine therapies. To explore regulatory boundaries in detail, consult our analysis of FDA regulations on regenerative medicine.
Because both use your own blood, infection and reaction risk is low but not zero. Documented procedural risks include:
- Injection-site pain.
- Bruising at the injection site.
- Rare infection.
Both products depend heavily on the preparation system and operator, so results and quality vary between clinics.
Out-of-Pocket Pricing and Quote Checklists
Health insurance plans almost never cover PRP, and Medical Frontier found no coverage information for PRF. Learn more about insurer positions in our guide on insurance coverage for PRP.
For PRP, Medical Frontier estimates that a single treatment session in the United States costs between $400 and $2,000 out of pocket. Typical protocols call for two to four sessions, raising total treatment costs accordingly. For a detailed breakdown of procedure fees, see our PRP injection cost guide.
For PRF, there is no reliable published national price range. Private practices set their own cash pricing.
Before committing to either therapy, obtain a written, itemized financial estimate from the provider. Confirm that your quote clarifies five details:
- The specific product being prepared, including whether the provider uses PRP, L-PRF, A-PRF, or i-PRF.
- The total number of blood draws and injection sessions included in the quoted package price.
- The specific centrifuge system and kit model used, so you can confirm its device clearance status.
- Any ancillary charges, such as imaging guidance.
- All consultation fees, follow-up visit charges, and cancellation policies.
Who This Is Not For
This page is not for readers looking for a verdict on which product works. It does not evaluate whether either treatment helps any condition, and it is not medical advice. Speak with a licensed clinician about your diagnosis.
What Would Change This Answer
Our assessment that neither concentrate holds a clinical advantage would change if researchers publish rigorous, randomized controlled clinical trials directly comparing PRP against PRF in human patients.
If future randomized trials in knee osteoarthritis or hair loss demonstrate that PRF delivers statistically significant and clinically meaningful improvements in pain or function over standard PRP, the comparison would need to be revisited. Until such trials are completed, claims of clinical superiority remain unsupported.
PRP vs PRF: How to Decide
When a provider offers a choice between PRP and PRF, use this sequential framework to evaluate the recommendation:
- Clarify the proposed clinical indication. Ask the clinician if their recommendation is based on published human clinical trials for your specific condition or on laboratory growth-factor studies.
- Inquire about the exact preparation protocol. Ask whether the clinic uses an anticoagulant, what centrifuge equipment is employed, and whether the final substance will be a liquid or a gel clot.
- Compare the itemized price difference. If a clinic charges a large cash premium for PRF over PRP, consider that no human clinical trials have established that PRF produces superior medical or cosmetic results.
- Review established non-regenerative options. Compare the proposed out-of-pocket costs and weak evidence base of autologous concentrates against covered medical alternatives with your primary physician.
The Bottom Line on PRP vs PRF
If you are being offered PRF or PRP and asked to pay more for one, our reading is this: it rests on Medical Frontier’s review of the published literature (one lab-only systematic review, Pereira 2023, and no clinical head-to-head trial found), not on our own testing. PRP and PRF are two ways of processing your own blood platelets, and the research we found does not prove that one treatment delivers superior clinical outcomes for patients. Laboratory studies indicate that PRF releases growth factors across a longer timeframe in test tubes, while PRP provides higher initial concentrations. However, laboratory cell releases do not equal symptom relief, hair growth, or joint recovery in living people. Because neither procedure holds FDA approval for these conditions and both require full out-of-pocket payment, patients should not pay an arbitrary cash premium based on unproven superiority claims.
This would change if randomized clinical trials in your specific use (knee, hair, or skin) show a difference. Request a written, itemized price quote from your clinic and verify whether their proposed blood concentrate protocol is supported by published human clinical data before scheduling an injection.
Frequently asked questions
What is the difference between PRP and PRF?
PRP (platelet-rich plasma) and PRF (platelet-rich fibrin) both come from your own blood, but they differ in how that blood is processed. PRP uses an anticoagulant and a faster centrifuge spin to produce a liquid plasma concentrated in platelets. PRF uses no anticoagulant and a slower centrifuge spin, forming a fibrin clot or gel where platelets are trapped.
Is PRF better than PRP?
Published evidence does not show that PRF is better than PRP for patients. Medical Frontier found no completed randomized head-to-head clinical trials comparing PRF with PRP for knee osteoarthritis, hair loss, or skin aesthetics. The available comparative evidence comes from laboratory tube testing rather than patient trials.
PRF vs PRP: which is better?
Neither treatment can be named superior for clinical use. Laboratory research shows that PRP releases more growth factors initially, while PRF releases growth factors over a longer period in test tubes. However, laboratory cell releases do not establish superior pain relief, tissue repair, or cosmetic outcomes in people.
Is PRF FDA-approved?
Medical Frontier did not find a Food and Drug Administration (FDA) approved PRF treatment. PRP preparation kits are cleared as medical devices, and a device clearance covers the equipment, not the use. Ask the clinic which device it uses and verify its clearance.
How much does PRF cost compared with PRP?
A single PRP session typically costs between $400 and $2,000 out of pocket, with multi-session series running higher. There is no reliable published national price range for PRF in the United States. Each private practice sets its own cash fee for PRF procedures.
Does PRF release growth factors longer than PRP?
In laboratory experiments, PRF appears to release growth factors over a longer timeframe. A 2023 systematic review of test-tube studies found that PRP had higher initial growth-factor levels, while advanced PRF showed better results after the tenth day. These findings have not been demonstrated in clinical patient outcomes.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.